Citadel Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.29M | Sell |
229,246
-763,396
| -77% | -$30.9M | ﹤0.01% | 1420 |
|
|
2025
Q1 | $51M | Buy |
992,642
+913,301
| +1,151% | +$46.9M | 0.01% | 470 |
|
|
2024
Q4 | $4.39M | Sell |
79,341
-305,126
| -79% | -$16.9M | ﹤0.01% | 1910 |
|
|
2024
Q3 | $12.6M | Buy |
384,467
+176,978
| +85% | +$5.82M | ﹤0.01% | 1105 |
|
|
2024
Q2 | $5.64M | Sell |
207,489
-11,789
| -5% | -$320K | ﹤0.01% | 1596 |
|
|
2024
Q1 | $7.97M | Buy |
219,278
+176,241
| +410% | +$6.41M | ﹤0.01% | 1432 |
|
|
2023
Q4 | $871K | Buy |
43,037
+37,173
| +634% | +$753K | ﹤0.01% | 3173 |
|
|
2023
Q3 | $104K | Sell |
5,864
-131,753
| -96% | -$2.34M | ﹤0.01% | 4824 |
|
|
2023
Q2 | $2.49M | Buy |
137,617
+85,361
| +163% | +$1.54M | ﹤0.01% | 2259 |
|
|
2023
Q1 | $657K | Buy |
52,256
+31,289
| +149% | +$393K | ﹤0.01% | 3609 |
|
|
2022
Q4 | $307K | Buy |
+20,967
| New | +$307K | ﹤0.01% | 4308 |
|
|
2022
Q3 | – | Sell |
-20,873
| Closed | -$305K | – | 6680 |
|
|
2022
Q2 | $305K | Sell |
20,873
-4,228
| -17% | -$61.8K | ﹤0.01% | 4619 |
|
|
2022
Q1 | $422K | Buy |
+25,101
| New | +$422K | ﹤0.01% | 4606 |
|